cancer – Page 2

cancer

Swiss pharmaceutical giant Roche acquires U.S. Cancer drug maker Ignyta for $1.7 billion

By admin1 on December 22, 2017 • ( 0 )

Ignyta’s precision drugs and diagnostic portfolio will help Roche increase its global footprint in the oncology department. On Friday, U.S. cancer drugmaker Ignyta Inc and Swiss drugmaker Roche disclosed that the Swiss pharmaceutical giant will acquire U.S. drugmaker for $1.7… Read More ›

French drugmaker Ipen set to acquire Merrimack’s asset for ~$1billion

By admin1 on January 9, 2017 • ( 0 )

While the deal will boost Ipen’s cancer drug portfolio, Merrimack’s shareholders will receive a special dividend as an outcome of the deal. France-based drug manufacturer Ipsen SA, has disclosed it will be acquiring some assets from its U.S. peer Merrimack… Read More ›